Noul, a Korean company specializing in AI-driven blood and cancer diagnostics, announced Monday that it has signed a three-year agreement with Indonesian medical device distributor PT Kirana Jaya Lestari to supply its AI-powered blood analysis solution, miLab BCM, to hospitals and screening centers across Indonesia.

Lim Chan-yang, CEO of Noul, said that Noul's miLab BCM is an “innovative product that could replace peripheral blood smears (PBS),” a procedure performed over 680 million times worldwide. “The product caters to both large and small diagnostic laboratories, and we are currently seeking U.S. Food and Drug Administration (FDA) clearance due to rising demand in Asia and developed countries,” he added. 

The miLab BCM automates the blood testing process, accurately distinguishing morphologically abnormal blood cells and providing digital images of each cell. Its compact design allows for easy installation and maintenance, making it suitable for various laboratory sizes. Noul said the system reduces the cost of implementing a digital pathology environment while requiring less skilled labor. Additionally, results can be viewed remotely, aligning with the growing trend of digital healthcare adoption in many countries.

Indonesia's telemedicine market is rapidly expanding, driven by its geography as an archipelago. The government's health system transformation plan aims to increase the absolute neutrophil count, which is expected to significantly boost the number of blood tests assessing white blood cells, red blood cells, and platelets.

Noul has also gained international recognition for its cancer diagnostics technology. A recent report by Unitaid, a global health initiative focused on bringing innovations to prevent, diagnose, and treat major diseases in low- and middle-income countries, recommended Noul's AI-powered cervical cancer diagnostic solution, miLab CER, for screening tests.

This recommendation places it alongside only three other products, including Roche's CINtec Plus Cytology, which uses dual staining technology, and Hologic’s ThinPrep Imaging System and Genius Digital Diagnostics System for computer-assisted cytology.